The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial
Article in Heliyon (April 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Heliyon (April 2024)
Article in Expert Review of Clinical Immunology (May 2023)
Article in Current Protein and Peptide Science (January 2023)